These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32190992)

  • 21. In vivo and autopsy validation of alpha-synuclein seeding activity using RT-QuIC assay in the gastrointestinal tract of patients with Parkinson's disease.
    Shin C; Han JY; Kim SI; Park SH; Yang HK; Lee HJ; Kong SH; Suh YS; Kim HJ; Choi YP; Jeon B
    Parkinsonism Relat Disord; 2022 Oct; 103():23-28. PubMed ID: 36029607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease.
    Cramm M; Schmitz M; Karch A; Mitrova E; Kuhn F; Schroeder B; Raeber A; Varges D; Kim YS; Satoh K; Collins S; Zerr I
    Mol Neurobiol; 2016 Apr; 53(3):1896-1904. PubMed ID: 25823511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.
    Landeck N; Hall H; Ardah MT; Majbour NK; El-Agnaf OM; Halliday G; Kirik D
    Mol Neurodegener; 2016 Aug; 11(1):61. PubMed ID: 27549140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson's disease.
    Bongianni M; Catalan M; Perra D; Fontana E; Janes F; Bertolotti C; Sacchetto L; Capaldi S; Tagliapietra M; Polverino P; Tommasini V; Bellavita G; Kachoie EA; Baruca R; Bernardini A; Valente M; Fiorini M; Bronzato E; Tamburin S; Bertolasi L; Brozzetti L; Cecchini MP; Gigli G; Monaco S; Manganotti P; Zanusso G
    Transl Neurodegener; 2022 Jul; 11(1):37. PubMed ID: 35902902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prion-Like Seeding of Misfolded α-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC.
    Sano K; Atarashi R; Satoh K; Ishibashi D; Nakagaki T; Iwasaki Y; Yoshida M; Murayama S; Mishima K; Nishida N
    Mol Neurobiol; 2018 May; 55(5):3916-3930. PubMed ID: 28550528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays.
    Candelise N; Schmitz M; Thüne K; Cramm M; Rabano A; Zafar S; Stoops E; Vanderstichele H; Villar-Pique A; Llorens F; Zerr I
    Transl Neurodegener; 2020; 9():5. PubMed ID: 31988747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of skin RT-QuIC in Parkinson's disease: a two-laboratory study.
    Kuzkina A; Bargar C; Schmitt D; Rößle J; Wang W; Schubert AL; Tatsuoka C; Gunzler SA; Zou WQ; Volkmann J; Sommer C; Doppler K; Chen SG
    NPJ Parkinsons Dis; 2021 Nov; 7(1):99. PubMed ID: 34782640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
    Russo MJ; Orru CD; Concha-Marambio L; Giaisi S; Groveman BR; Farris CM; Holguin B; Hughson AG; LaFontant DE; Caspell-Garcia C; Coffey CS; Mollon J; Hutten SJ; Merchant K; Heym RG; Soto C; Caughey B; Kang UJ
    Acta Neuropathol Commun; 2021 Nov; 9(1):179. PubMed ID: 34742348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease.
    Ruffmann C; Bengoa-Vergniory N; Poggiolini I; Ritchie D; Hu MT; Alegre-Abarrategui J; Parkkinen L
    Neuropathol Appl Neurobiol; 2018 Dec; 44(7):722-736. PubMed ID: 29676021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of alpha-synuclein aggregates in gastrointestinal biopsies by protein misfolding cyclic amplification.
    Fenyi A; Leclair-Visonneau L; Clairembault T; Coron E; Neunlist M; Melki R; Derkinderen P; Bousset L
    Neurobiol Dis; 2019 Sep; 129():38-43. PubMed ID: 31078683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blinded RT-QuIC Analysis of α-Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients.
    Manne S; Kondru N; Jin H; Serrano GE; Anantharam V; Kanthasamy A; Adler CH; Beach TG; Kanthasamy AG
    Mov Disord; 2020 Dec; 35(12):2230-2239. PubMed ID: 32960470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid α-synuclein seed assay of Parkinson's disease CSF panel shows high diagnostic accuracy.
    Orrù CD; Ma TC; Hughson AG; Groveman BR; Srivastava A; Galasko D; Angers R; Downey P; Crawford K; Hutten SJ; Kang UJ; Caughey B
    Ann Clin Transl Neurol; 2021 Feb; 8(2):374-384. PubMed ID: 33373501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The intracellular milieu of Parkinson's disease patient brain cells modulates alpha-synuclein protein aggregation.
    Gustavsson N; Savchenko E; Klementieva O; Roybon L
    Acta Neuropathol Commun; 2021 Sep; 9(1):153. PubMed ID: 34530929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.
    Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG
    J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo.
    Marmolino D; Foerch P; Atienzar FA; Staelens L; Michel A; Scheller D
    Mol Cell Neurosci; 2016 Mar; 71():92-101. PubMed ID: 26711807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitive and specific detection of classical scrapie prions in the brains of goats by real-time quaking-induced conversion.
    Dassanayake RP; Orrú CD; Hughson AG; Caughey B; Graça T; Zhuang D; Madsen-Bouterse SA; Knowles DP; Schneider DA
    J Gen Virol; 2016 Mar; 97(3):803-812. PubMed ID: 26653410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids.
    Candelise N; Baiardi S; Franceschini A; Rossi M; Parchi P
    Acta Neuropathol Commun; 2020 Jul; 8(1):117. PubMed ID: 32711575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluid and Biopsy Based Biomarkers in Parkinson's Disease.
    Coughlin DG; Irwin DJ
    Neurotherapeutics; 2023 Jul; 20(4):932-954. PubMed ID: 37138160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-Molecule Counting Coupled to Rapid Amplification Enables Detection of α-Synuclein Aggregates in Cerebrospinal Fluid of Parkinson's Disease Patients.
    Bhumkar A; Magnan C; Lau D; Jun ESW; Dzamko N; Gambin Y; Sierecki E
    Angew Chem Int Ed Engl; 2021 May; 60(21):11874-11883. PubMed ID: 33511725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid.
    Kalia LV
    Parkinsonism Relat Disord; 2019 Feb; 59():21-25. PubMed ID: 30466800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.